Management of anemia and febrile neutropenia in patients treated for malignancy

Authors

  • June Landa Alberdi Donostia Unibertsitate Ospitalea
  • Larraitz Leunda Eizmendi Donostia Unibertsitate Ospitalea
  • Miren Ercilla Liceaga Mendaro Ospitalea
  • Maitane Umerez Igartua Mendaro Ospitalea
  • Aitziber Lizardi Mutuberria Elizondo Lanbide Eskola
  • Miren Josune Garcia de Andoin Barandiaran Donostia Unibertsitate Ospitalea
  • Mikel Urretavizcaya Anton Donostia Unibertsitate Ospitalea eta Onkologikoa Fundazioa
  • Idoia Beristain Aramendi Donostia Unibertsitate Ospitalea
  • Leire Ulacia Epelde Donostia Unibertsitate Ospitalea

Keywords:

anemia, neutropenia, chemotherapy

Abstract

Anemia and febrile neutropenia are common complications among oncology patients that are being treated with chemotherapy. It is important to get an early diagnosis and treatment of these undesirable side effects, as both have a negative impact on life quality and mortality.

Author Biographies

June Landa Alberdi, Donostia Unibertsitate Ospitalea

Ospitaleko Farmazian Espezialista

Larraitz Leunda Eizmendi, Donostia Unibertsitate Ospitalea

Farmazia Zerbitzua

Miren Ercilla Liceaga, Mendaro Ospitalea

Farmazia Zerbitzua

Maitane Umerez Igartua, Mendaro Ospitalea

Farmazia Zerbitzua

Miren Josune Garcia de Andoin Barandiaran, Donostia Unibertsitate Ospitalea

Farmazia Zerbitzua

Mikel Urretavizcaya Anton, Donostia Unibertsitate Ospitalea eta Onkologikoa Fundazioa

Farmazia Zerbitzua

Idoia Beristain Aramendi, Donostia Unibertsitate Ospitalea

Farmazia Zerbitzua

Leire Ulacia Epelde, Donostia Unibertsitate Ospitalea

Farmazia Zerbitzua

References

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, Hofmann A, Link H, Littlewood T, Ludwig H, Österborg A, Pronzato P, Santini V, Schrijvers D, Stauder R, Jordan K, Herrstedt J, on behalf of the ESMO Guidelines Committee. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29 (Supplement 4): iv96–iv110.

National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology; Hematopoietic growth factors. v.2.2020, 2020.

Douglas Rizzo J, Browers M, Hurley P, Seidenfeld J, Somerfield MR, Temin S. American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the use or epoetin and darbepoetin in adult patients with cancer. Blood. 2010; 116: 4045-4059.

Flores Balcázar C, Rosales Pérez S, Galván Salazar G, López Navarro O. Anemia inducida por quimioterapia en pacientes oncológicos: papel de los agentes eritropoyéticos. iMedPub Journals. 2015; 11 doi: 10.3823/1217.

WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1) [Kontsulta 2023/04/05]. Eskuragarri:

https://apps.who.int/iris/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf

Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrsdt J, on behalf of the ESMO Guidelines Committee. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines, Annals of Oncology, Volume 27, Issue suppl_5, 1 September 2016, Pages v111–v118, https://doi.org/10.1093/annonc/mdw325

National Comprehensive Cancer Network. NCCN Practice Guidelines in Oncology; Prevention and treatment of cancer-related infections. v.1.2020, 2019.

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO, on behalf of the American Society of Clinical Oncology. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2015; 33: 3199-3212.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018; 36: 1443-1453.

Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR. Antimicrobial Prophylaxis for Adult Patients With Cancer Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018; 36: 3043-3054.

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Peter Donelly J, Kearny N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, on behalf of the European Organisation for Research and Treatment of Cancer. 2010 Update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer. 2011; 47: 8-32.

Comité de Política Antibiótica- Hospital Universitario Donostia. Guía de tratamiento empírico de las enfermedades infecciosas. 2ª Edición. Donostia: Comunicación OSI Donostialdea; 2017.

Mensa J. et al. Guía de terapéutica antimicrobiana. Edición del 2022. Barcelona: Antares; 2022.

Downloads

Published

2024-06-27

How to Cite

Landa Alberdi, J., Leunda Eizmendi, L., Ercilla Liceaga, M., Umerez Igartua, M., Lizardi Mutuberria, A., Garcia de Andoin Barandiaran, M. J., Urretavizcaya Anton, M., Beristain Aramendi, I., & Ulacia Epelde, L. (2024). Management of anemia and febrile neutropenia in patients treated for malignancy. Osagaiz: Osasun-Zientzien Aldizkaria, 8(1), 101–106. Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/567